Activation of the Urokinase plasminogen activator/Urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing met

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 201-212

  Paciucci, Rosanna ^a   Vilá, Maya R ^a   Adell, Teresa ^a   Díaz, Víctor M ^a   Torà, Montserrat ^a   Nakamura, Toshikazu ^b   Real, Francisco X ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; UROKINASE; UROKINASE RECEPTOR; UVOMORULIN;

ARTICLE; CELL MOTILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MITOGENESIS; NORTHERN BLOTTING; PANCREAS TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031847206     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65561-7     Document Type: Article

References (67)

1. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W: Scatter factor: molecular characteristics and effect on the invasiveness. J Cell Biol 1990, 111:2097-2108
2. Gherardi E, Stoker M: Hepatocytes and scatter factor. Nature 1991, 346:228
3. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991, 88:7002-7005
4. Rosen EM, Nigam SK, Goldberg ID: Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994, 127:1783-1787
5. Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995, 129:1177-1180
6. Vilá MR, Nakamura T, Real FX: Hepatocyte growth factor is a potent mitogen for normal human pancreas cells in vitro. Lab Invest 1995, 73:409-418
7. Montesano R, Matsumoto K, Nakamura T, Orci L: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991, 67:901-908
8. Cooper CS: The met oncogene: from detection by transfection to transmembrane receptor for hepatocyte growth factor. Oncogene 1992, 7:3-7
9. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C: Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993, 123:223-235
10. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschlesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995, 373:699-702
11. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995, 373:702-705
12. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF: Met expression and sarcoma tumorigenicity. Cancer Res 1993, 53:5355-5360
13. Ferracini R, Di Renzo MF, Scotland K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M, Comoglio PM: The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995, 10:739-749
14. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF: Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994, 91:4731-4735
15. Jeffers M, Rong S, Vande Woude GF: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 1996, 16:1115-1125
16. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaughnessy P, Goldberg ID, Rosen EM: Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 1995, 87:372-376
17. Ridley AJ, Comoglio PM, Hall A: Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. J Cell Biol 1995, 15:1110-1122
18. Royal I, Park M: Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem 1995, 270:27780-27787
19. Ponzetto C, Zhen Z, Audero E, Maina F, Bardelli A, Basile ML, Giordano S, Narsimhan R, Comoglio P: Specific uncoupling of GRB2 from the Met receptor. J Biol Chem 1996, 271:14119-14123
20. Boccaccio C, Andò M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM: Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 1998, 391:285-288
21. Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R: Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 1992, 267:20493-20496
22. Boccaccio C, Gaudino G, Gambarotta G, Galimi F, Comoglio PM: Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem 1994, 269:12846-12851
23. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992, 11:4825-4833
24. Mars WM, Zarnegar R, Michalopoulos GK: Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993, 143:949-958
25. Kern HF, Elsässer H-P: Fine structure of human pancreatic adenocarcinoma. The Pancreas: Biology, Pathobiology, and Disease. Edited by VLW Go, EP DiMagno, JD Gardner, E Lebenthal, HA Reber, GA Scheele. New York, Raven Press, 1993, pp 857-869
26. Ebert M, Yokoyama M, Friess H, Büchler MW, Korc M: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994, 54:5775-5778
27. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR: Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995, 55:1129-1138
28. Furukawa T, Duguid WP, Kobari M, Matsuno S, Tsao M-T: Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol 1995, 147:889-895
29. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985, 44:139-266
30. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992, 11:291-311
31. Vilá MR, Lloreta J, Real FX: Normal human pancreas cultures display functional ductal characteristics. Lab Invest 1994, 71:423-431
32. Vilá MR, Lloreta J, Schüssler MH, Berrozpe G, Welt S, Real FX: New pancreas cancer cell lines which represent distinct stages of ductal differentiation. Lab Invest 1995, 72:395-404
33. Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, Zarnegar R, Michalopoulos GA, Nakamura T, Faletto D, Rosen EM: Scatter factor and hepatocyte growth factor: activities, properties, and mechanisms. Cell Growth Differ 1992, 3:11-20
34. Fabre M, García de Herreros A: Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin. J Cell Sci 1993, 106:513-522
35. Hiraki Y, Rosen OM, Birnbaum MJ: Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 1988, 263:13655-13662
36. Skoudy A, Llosas MM, García de Herreros A: Intestinal HT-29 cells with dysfunction of E-cadherin show increased pp60src activity, and tyrosine phosphorylation of p120-catenin. Biochem J 1996, 317:279-284
37. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrate. Anal Biochem 1990, 102:196-202
38. Lisanti MP, Le Bivic A, Saltiel AR, Rodríguez-Boulan E: Preferred apical distribution of glycosyl phosphatidylinositol (GPI)-anchored proteins: a highly conserved feature of the polarized epithelial cell phenotype. J Membr Biol 1990, 113:155-167
39. Chomczynski P, Sacchi N: Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
40. Feinberg AP, Volgelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983, 132:6-13
41. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM: Tyrosine kinase receptor indistinguishable from the c-Met protein. Nature 1989, 339:155-156
42. Vassalli JD, Belin D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987, 214:187-191
43. Paciucci R, Berrozpe G, Torà M, Navarro E, García de Herreros A, Real FX: Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization. FEBS Lett 1996, 385:72-76
44. Stahl A, Mueller BM: The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 1995, 129:335-344
45. Lisanti MP, Scherer PE, Vidgiriene J, Tang ZL, Hermanowski-Vosatka A, Tu Y-H, Cook RF, Sargiacomo M: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994, 126:111-126
46. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem 1990, 265:6453-6460
47. Ploug M, Ellis V, Dano K: Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate: evidence for a hydrophobic binding site exposed on the intact receptor. Biochemistry 1994, 33:8991-8997
48. Hinck L, Nelson WJ, Papkoff J: Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing β-catenin binding to the cell adhesion protein cadherin. J Cell Biol 1994, 124:729-741
49. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF: The met proto-oncogene receptor, and lumen formation. Science 1992, 257:1258-1261
50. Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL: Hepatocyte growth factor/scatter factor effects on epithelia: regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest 1994, 93:2056-2065
51. Crepaldi T, Pollack AL, Prat M, Zborek A, Mostov K, Comoglio PM: Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J Cell Biol 1994, 125:313-320
52. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM: Expression of scatter and c-met receptor in benign and malignant breast tissue. Cancer 1996, 79:749-760
53. Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y: Enhancement of human hepatocyte growth factor production by interleukin-1α and 1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 1993, 268:8140-8145
54. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R: Modulation of c-met proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-met transcript. Oncogene 1994, 9:2045-2052
55. Thomson TM, Green SH, Trotta RJ, Burstein DE, Pellicer A: Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor, and basic fibroblast growth factor in a PC12 cell line. Mol Cell Biol 1990, 10:1556-1563
56. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996, 2:287-292
57. Montesano R, Orci L: Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985, 42:469-477
58. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massagué J: Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 1996, 271:11376-11382
59. Sevinsky JR, Rao LVM, Ruf W: Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 1996, 133:293-304
60. Hoyer-Hansen G, Rone E, Solberg H, Behrendt N, Ploug M, Lund LR, Ellis V, Dano K: Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem 1992, 267:18224-18229
61. Resnati M, Guttinger M, Valcamonica F, Sidenius N, Blasi F, Fazioli F: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 1996, 15:1572-1582
62. Stefansson S, Lawrence DA: The serpin PAI-1 inhibits cell migration by blocking integrin αV/β3 binding to vitronectin. Nature 1996, 383:441-443
63. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ: Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 1996, 134:1563-1571
64. Birchmeier W, Weidner KM, Behrens J: Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci 1993, 17:159-164
65. Hordijk P, Ten Klooster JP, Van der Kammen RA, Michiels F, Oomen L, Collar JG: Inhibition of invasion of epithelial cells by Tiam 1-Rac signaling. Science 1997, 278:1464-1466
66. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M, Ito F: Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepalocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1994, 1:295-305
67. Paciucci R, Torà M, Díaz VM, Real FX: The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 1998, 16:625-634